Filing Details

Accession Number:
0001209191-11-028786
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-16 21:56:05
Reporting Period:
2011-05-12
Filing Date:
2011-05-16
Accepted Time:
2011-05-16 21:56:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087432 Intermune Inc ITMN Pharmaceutical Preparations (2834) 943296648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1212689 John Hodgman 3280 Bayshore Blvd.
Brisbane CA 94005
Svp-Finance & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-05-12 18,227 $15.34 40,227 No 4 M Direct
Common Stock Acquisiton 2011-05-12 125,000 $15.19 165,227 No 4 M Direct
Common Stock Disposition 2011-05-12 143,227 $40.00 22,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-05-12 18,227 $0.00 18,227 $15.34
Common Stock Stock Option (Right to Buy) Disposition 2011-05-12 125,000 $0.00 125,000 $15.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,773 2018-05-13 No 4 M Direct
0 2016-08-14 No 4 M Direct
Footnotes
  1. Twenty-five percent (25%) of the total number of shares subject to the stock option vest and become exercisable on the first anniversary of the grant date. The remainder of the option shares vests and becomes exercisable cumulatively in equal monthly installments over the following thirty-six (36) months.
  2. Fully exercisable.